biomedicina slovenica

re="Cancer" : 8-107

  1. Ocaña Alberto; Amir Eitan; Šeruga Boštjan; Martin Miguel; Pandiella Atanasio
    The evolving landscape of protein kinases in breast cancer: clinical implications
    2013 ►
  2. Merlo Domenico Franco; Primic-Žakelj Maja
    Breast cancer incidence trends in European women aged 20-39 years at diagnosis
    2012 ►
  3. Lukanovič Adolf
    Long term consequences of cervical cancer treatment
    2012 ►
  4. Kocjan Boštjan J; Seme Katja; Cimerman Mojca; Kovanda A; Potočnik Marko; Poljak Mario
    Genomic diversity of human papillomavirus (HPV) genotype 38
    2008 ►
  5. Kocjan Boštjan J; Poljak Mario; Seme katja; Fujs Kristina; Potočnik Marko
    Distribution of human papillomavirus genotypes in Slovenian patients wirh common cutaneous warts
    2004 ►
  6. Kocjan BJ; Seme K; Poljak M
    Evaluation of the abbott realtime high risk HPV test for the detection and identification of human papillomaviruses in archival cervical cancer speciments
    2011 ►
  7. Jentschke Matthias; Soergel Philipp; Lange Victoria; Kocjan Boštjan; Doerk Thilo; Luyten Alexander; Petry Karl Urlich; Poljak Mario; Hillemanns Peter
    Evaluation of a new multiplex real-time polymerase chain reaction assay for the detection of human papillomavirus infections in a referral population
    2012 ►
  8. Siesling Sabine; Primic-Žakelj Maja
    Rare thoracic cancers, including peritoneum mesothelioma
    2012 ►
  9. Sodja Eva; Knez Lea; Kern Izidor; Ovčariček Tanja; Sadikov Aleksander; Čufer Tanja
    Impact of ERCC1 expression on treatment outcome in small-cell lung cancer patients treated with platinum-based chemotherapy
    2012 ►
  10. Poljšak Borut; Glavan Uroš; Dahmane Raja
    Skin cancer, free radicals and antioxidants
    2011 ►
  11. Uršič-Vrščaj Marjetka; Poljak Mario
    Use of high-risk human papilloma virus testing in cervical cancer control
    2012 ►
  12. Kocjan Boštjan J; Poljak Mario
    Human papillomaviruses in cervical carcinogenesis
    2012 ►
  13. Erčulj Nina; Faganel-Kotnik Barbara; Debeljak Maruša; Jazbec Janez; Dolžan Vita
    DNA repair polymorphisms influence the risk of second neoplasm after treatment of childhood acute lymphoblastic leukemia
    2012 ►
  14. Plesničar Andrej; Urbančič Klaudia; Mlinar Suzana; Kralj Božo; Kovač Viljem; Kores-Plesničar Blanka
    Early detection and prevention of breast cancer: the increasing importance of midwives in the future
    2012 ►
  15. Ocvirk Janja; Boc Marko; Mesti Tanja
    Long-term survival of a patient with mCRC treated with ERBITUX and chemotherapy
    2012 ►
  16. Reberšek Martina; Boc Marko
    A case of long-term survival in mCRC patient with adenocarcinoma of the sigmoid colon after curative liver surgery (followed by neoadjuvant treatment with ERBITUX plus chemotherapy) and maintenace with ERBITUX
    2012 ►
  17. Ocvirk Janja; Boc Marko
    Long-term survival of a patient with mCRC treated with ERBITUX and chemotherapy followed by ERBITUX maintenance
    2012 ►
  18. Knez L; Košnik M; Ovčariček T; Sadikov A; Sodja E; Kern I; Čufer T
    Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy
    2012 ►
  19. Černe Jasmina Živa; Stegel Vida; Geršak Ksenija; Novaković Srdjan
    KRAS rs61764370 is associated with HER2-overexpressed and poorly-differentiated breast cancer in hormone replacement therapy users: a case control study
    2012 ►
  20. Gatta Gemma; Primic-Žakelj Maja
    Rare cancers are not so rare: the rare cancer burden in Europe
    2011 ►
  21. Trama A; Mallone S; Nicolai N; Necchi A; Schaapveld M; Gietema J; Znaor A; Ardanz E; Berrino F; Primic-Žakelj Maja
    Burden of testicular, paratesticular and extragonadal germ cell tumours in Europe
    2012 ►
  22. Perše Martina
    Physical activity, dietary fat and colorectal cancer
    2012 ►
  23. Perše M; Injac R; Štrukelj B; Cerar A
    High fat mixed lipid diet modifies protective effects of exercise on 1,2 dimethylhydrazine induced colon cancer in rats
    2012 ►
  24. Sorbe B; Nordstrom B; Maenpaa J; Kuhelj J; Kuhelj D; Okkan S; Delaloye JF; Frankendal B
    Intravaginal brachytherapy in FIGO stage I low-risk endometrial cancer: a controlled randomized study
    2009 ►
  25. Prijič Sara; Prosen Lara; Čemažar Maja; Žnidaršič Andrej; Serša Gregor
    Magnetofection of reporter and therapeutic genes into different cell lines
    2011 ►
  26. von Minckwitz Gunter; Schwedler Kathrin; Schmidt Marcus; Čufer Tanja
    Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer
    2011 ►
  27. Regan MM; Price KN; Giobbie-Hurder A; Thuerliman B; Gelber RD; Čufer T; Pajk B; Červek J
    Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
    2011 ►
  28. Trobec Katja; Knez Lea; Meško-Brguljan Pika; Čufer Tanja; Lainščak Mitja
    Estimation of renal function in lung cancer patients
    2012 ►
  29. Serša Gregor; Čufer Tanja; Paulin-Košir Marija Snežna; Čemažar Maja; Snoj Marko
    Electrochemotherapy of chest wall breast cancer recurrence
    2011 ►
  30. Amir Eitan; Šeruga Boštjan; Niraula Saroj; Carlsson Lindsay; Ocaña Alberto
    Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis
    2011 ►
  31. Amir Eitan; Šeruga Boštjan; Kwong Ryan; Tannock Ian; Ocaña Alberto
    Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer?
    2012 ►
  32. Kobal B; Cvjetičanin B; Meglič L; Smrkolj Š; Vakselj A; Barbič M
    Treatment outcome in patients with not optimal resectable peritoneal form of stage III ovarian cancer
    2011 ►
  33. Smrkolj Š; Rakar S
    The clinical outcome of patients with figo stage IA2 squamous cell carcinoma of the uterine cervix
    2011 ►
  34. Jabrane-Ferrat N; Campbell MJ; Esserman LJ; Peterlin BM
    Challenge with mammary tumor cells expressing MHC class II and CD80 prevents the development of spontaneously arising tumors in MMTV-neu transgenic mice
    2006 ►
  35. Van Dijk BAC; Gatta Gemma; Capocaccia R; Pierannunzio Daniela; Strojan Primož; Licitra Lisa
    Rare cancers of the head and neck area in Europe
    2012 ►
  36. Černe Jasmina-Živa; Geršak Ksenija; Novaković Srdjan
    The influence of the genetic variant within miRNA-binding site in estrogen receptor alpha gene on the risk of breast cancer in postmenopausal women on hormone replacement therapy
    2011 ►
  37. Pakiž Maja; Potočnik Uroš; But Igor; Mujezinović Faris
    A CYP17A1 gene polymorphism in association with multiple uterine leimyomas; a meta-analysis
    2011 ►
  38. Perić Barbara; Žagar Ivana; Novaković Srdjan; Žgajnar Janez; Hočevar Marko
    Role of serum S100B and PET-CT in follow-up of patients with cutaneous melanoma
    2011 ►
  39. Edhemović Ibrahim; Gadžijev Eldar; Brecelj Erik; Miklavčič Damijan; Kos Bor; Županič Anže; Mali Barbara; Jarm Tomaž; Pavliha Denis; Marčan Marija; Gašljević Gorana; Gorjup Vesna; Marolt-Mušič Maja; Pečnik-Vavpotič Tjaša; Čemažar Maja; Snoj Marko; Serša Gregor
    Electrochemotherapy: a new technological approach in treatment of metastases in the liver
    2011 ►
  40. Hu-Lieskovan Siwen; Bračko Matej; Velenik Vaneja
    EGF61 polymorphism predicts complete pathologic response to cetuximab-based chemoradiation independent of KRAS status in locally advanced rectal cancer patients
    2011 ►
  41. Bosetti Cristina; Pompe-Kirn Vera
    High constant incidence rates of second primary cancers of the head and neck: #a #pooled analysis of 13 cancer registries
    2011 ►
  42. Hmeljak Julija; Erčulj Nina; Dolžan Vita; Kern Izidor; Coer Andrej
    BIRC5 promoter SNPs do not affect nuclear survivin expression and survival of malignant pleural mesothelioma patients
    2011 ►
  43. Rotar-Pavlič D; Visentin D; Peris D
    European forum for primary care - workshop primary care teams are important part of the chain
    2011 ►
  44. Knez Lea; Sodja Eva; Kern Izidor; Košnik Mitja; Čufer Tanja
    Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: a systematic review
    2011 ►
  45. Bränström Richard; Hočevar Marko; Perić Barbara
    Predictors of sun protection behaviors and severe sunburn in an international online study
    2010 ►
  46. Kloboves-Prevodnik Veronika; Lavrenčak Jaka; Horvat Mateja; Jezeršek Novaković Barbara
    The predictive significance of CD20 expression in B-cell lymphomas
    2011 ►
  47. Bränström Richard; Hočevar Marko; Perić Barbara
    Melanoma risk factors, perceived threat and intentional tanning: an international online survey
    2010 ►
  48. Glavač Damjan
    MicroRNAs in skin morphogenesis and diseases
    2011 ►
  49. Rosso Stefano; Primic-Žakelj Maja; Žagar Tina
    Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: the role of screening and a comparison with data from the United States
    2010 ►
  50. Amir Eitan; Šeruga Boštjan; Serrano Rosario; Ocaña Alberto
    Targeting DNA repair in breast cancer: a clinical and translational update
    2010 ►
  51. Matos Erika; Škrbinc Breda; Zakotnik Branko
    Fertility in patients treated for testicular cancer
    2010 ►
  52. Čufer Tanja; Vrdoljak Eduard; Gaafar Rabab; Erensoy Inci; Pomberton Kristine
    Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (Iressa) of docetaxel as second-line theapy in patients with advanced (stage IIIB of IV) non-small-cell lung cancer
    2010 ►
  53. Čufer Tanja
    Barriers and challenges for academic cancer research
    2010 ►
  54. Čufer Tanja
    Translation research on new molecular markers: an EORTC BCG experinece
    2010 ►
  55. Vogelsang M; Komel R
    Non-truncating hMLH1 variants identified in Slovenian gastric cancer patients are not associated with Lynch syndrome: a functional analysis report
    2011 ►
  56. Amir Eitan; Freedman Orit C; Šeruga Boštjan; Evans Gareth D
    Assessing women at high risk of breast cancer ea review of risk assessment models
    2010 ►
  57. Amir Eitan; Ocaña Alberto; Šeruga Boštjan; Freedman Orit; Clemons Mark
    Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancer
    2010 ►
  58. Hevir Neli; Šinkovec Jasna; Lanišnik-Rižner Tea
    Disturbed expression of phase I and II oestrogen-metabolizing enzymes in endometrial cancer
    2010 ►
  59. Pirker Robert; Zakotnik Branko; Zwitter Matjaž
    Therapy of small cell lung cancer with emphasis on oral topotecan
    2010 ►
  60. Šeruga Boštjan; Amir Eitan
    Cytochrome P450 2D6 and outcomes of adjuvant tamoxifen therapy: results of a meta-analysis
    2010 ►
  61. Borštnar Simona; Sadikov Aleksander; Možina Barbara; Čufer Tanja
    High levels of uPA and PAI-1 predict a good response to anthracyclines
    2010 ►
  62. Kenig S; Majdič T; Duran-Alonso MB; Lah T
    Endothelial cells increase invasiveness of glioblastoma cells and protect them from apoptosis
    2010 ►
  63. Španinger K; Matos E; Možina B; Borštnar S; Sytkowski AJ; Komel R; Debeljak N
    Isoelectric focusing: method for detection of total erythropoietin in urine and plasma in cancer patients
    2010 ►
  64. Chuang Shu-Chun; Pompe-Kirn Vera
    Risk of second primary cancer among patients with major histological types of lung cancers in both men and women
    2005 ►
  65. Sant Milena; Primic-Žakelj Maja
    EUROCARE-4, survival of cancer patients diagnosed in 1995-1999: results and commentary
    2009 ►
  66. Sant Milena; Primic-Žakelj Maja
    Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study
    2007 ►
  67. Gondos A.; Primic-Žakelj Maja
    Recent trends in cancer survival across Europe between 2000 and 2004: #a #model-based period analysis from 12 cancer registries
    2008 ►
  68. Robins G.; Primic-Žakelj Maja; Potočnik Marjeta
    International variation in Helicobacter pylori infection and rates of oesophageal cancer
    2008 ►
  69. Bouvier Anne-Marie; Pompe-Kirn Vera
    What reasons lie behind long-term survival differences for gastric cancer within Europe?
    2010 ►
  70. Lepage Côme; Pompe-Kirn Vera; Primic-Žakelj Maja
    European disparities in malignant digestive endocrine tumours survival
    2010 ►
  71. De Angelis Roberta; Primic-Žakelj Maja
    The EUROCARE-4 database on cancer survival in Europe: data standardisation, quality control and methods of statistical analysis
    2009 ►
  72. Berrino Franco; Primic-Žakelj Maja
    Comparative cancer survival information in Europe
    2009 ►
  73. Quaglia Alberto; Primic-Žakelj Maja
    The cancer survival gap between elderly and middle-aged patients in Europe is widening
    2009 ►
  74. Gatta Gemma; Primic-Žakelj Maja
    Survival of European children and young adults with cancer diagnosed 1995-2002
    2009 ►
  75. Anttila Ahti; Primic-Žakelj Maja; Pogačnik Ana; Uršič-Vrščaj Marjetka; Zadnik Vesna
    Description of the national situation of cervical cancer screening in the member states of the European Union
    2009 ►
  76. Rosso Stefano; Primic-Žakelj Maja
    Multiple tumours in survival estimates
    2009 ►
  77. Francisci Silvia; Primic-Žakelj Maja
    The cure of cancer: a European perspective
    2009 ►
  78. Verdecchia Arduino; Primic-Žakelj Maja
    Survival trends in European cancer patients diagnosed from 1988 to 1999
    2009 ►
  79. Brenner Hermann; Primic-Žakelj Maja
    Long-term survival expectations of cancer patients in Europe in 2000-2002
    2009 ►
  80. Micheli Andrea; Primic-Žakelj Maja
    The advantage of women in cancer survival: an analysis of EUROCARE-4 data
    2009 ►
  81. Ravnik M; Snoj N; Sadikov A; Nussdorfer P; Čufer T
    Comparison of adjuvant! Online prediction with 10-year follow-up results according to the uPA and PAI-1 levels in Slovenian early breast cancer patients
    2010 ►
  82. Jančar N; Vrtačnik-Bokal E; Šinkovec J; Kocjan BJ; Poljak M
    Distribution of HPV genotypes in women with cervical cancer in Slovenia and genomic variants of HPV 16, HPV 18 and HPV 33
    2010 ►
  83. Perhavec Andrež; Pohar-Perme Maja; Hočevar Marko; Bešić Nikola; Žgajnar Janez
    Ljubljana nomograms for predicting the likelihood of non-sentinel lymph node metastases in breast cancer patients with a positive sentinel lymph node
    2010 ►
  84. Maule Milena M.; Pompe-Kirn Vera
    Risk of second malignant neoplasms after childhood central nervous system malignant tumours: #an #international study
    2008 ►
  85. Glavač D
    Diagnostic importance of methylation detection in colorectal cancer
    2009 ►
  86. Glavač Damjan
    Molecular diagnostics of multiple endocrine neoplasia type 2 (MEN II)
    2009 ►
  87. Ravnik-Glavač Metka; Glavač Damjan
    Molecular genetic approaches for screening of patients with hereditary non-poliposis colorectal cancer and genetic counseling
    2009 ►
  88. Glavač Damjan; Potočnik Uroš; Ravnik-Glavač Metka
    New genes mutated within coding mononucleotide repeats in colorectal tumors with high microsatellite instability (Msi)
    2009 ►
  89. Rokavec Matjaž; Schroth Werner; Amaral Sandra M; Fritz Peter; Antoniadou Lydia; Glavač Damjan; Simon Wolfang; Schwab Matthias; Eichelbaum Michel; Brauch Hiltrud
    A polymorphism in the TC21 promoter associates with an unfavorable tamoxifen treatment outcome in breast cancer
    2008 ►
  90. Berginc Gašper; Bračko Matej; Glavač Damjan
    MS-MLPA reveals progressive age-dependent promoter methylation of tumor suppressor genes and possible role of IGSF4 gene in colorectal carcinogenesis of microsatellite instable tumors
    2010 ►
  91. Barzon Luisa; Trevisan Marta; Matkovič Urška; Pacenti Monia; Palu Giorgio
    Role of oncogenic viruses in the pathogenesis of adrenal tumors
    2008 ►
  92. Pacenti M; Matkovič U; Barzon L; Palu G
    Evaluation of adenovirus infection and toxicity in human adrenocortical cells
    2006 ►
  93. Serša Gregor
    Electrochemotherapy in treatment of cutaneous tumors
    2010 ►
  94. Pavlin Darja; Čemažar Maja; Kamenšek Urška; Tozon Nataša; Pogačnik Azra; Serša Gregor
    Local and systemic antitumor effect of intratumoral and peritumoral IL-12 electrogene therapy on murine sarcoma
    2009 ►
  95. Pasanisi Patrizia; Primic-Žakelj Maja; Zadnik Vesna
    Oral contraceptive use and BRCA penetrance: #a #case-only study
    2009 ►
  96. Kokalj-Vokač Nadja; Kodrič Tatjana; Erjavec Škerget Alenka; Zagorac Andreja; Takač Iztok
    Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions
    2009 ►
  97. Mlakar Vid; Stražišar Mojca; Sok Mihael; Glavač Damjan
    Oligonucleotide DNA microarray profiling of lung adenocarcinoma revealed significant downregulation and deletions of vasoactive intestinal peptide receptor 1
    2009 ►
  98. Korde Larissa A; Lusa Lara; McShane Lisa; Lebowitz Peter F; Lukes LuAnne; Camphausen Kevin; Parker Joel S; Swain Sandra M; Hunter Kent; Zujewski Jo Anne
    Gene expression pathway analysis to predict response to neoadjuvant docetaxel and capecitabine for breast cancer
    2009 ►
  99. Rotar-Pavlič Danica; de Graaf Pim
    Chronic cancer care in primary care: emerging needs, emerging innovations
    2009 ►
  100. Berginc Gašper; Bračko Matej; Ravnik-Glavač Metka; Glavač Damjan
    Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome
    2009 ►

   1 8 108 208 308 408 508 608 708  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics